Cargando…
Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors
PURPOSE: More employees are experiencing a cancer diagnosis during their working-age years, yet there have been no large-scale Japanese studies investigating sick leave due to cancer. We clarified differences in the cumulative partial and full return to work (RTW) rates between different cancer type...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801999/ https://www.ncbi.nlm.nih.gov/pubmed/26318185 http://dx.doi.org/10.1007/s11764-015-0478-3 |
_version_ | 1782422645935964160 |
---|---|
author | Endo, Motoki Haruyama, Yasuo Takahashi, Miyako Nishiura, Chihiro Kojimahara, Noriko Yamaguchi, Naohito |
author_facet | Endo, Motoki Haruyama, Yasuo Takahashi, Miyako Nishiura, Chihiro Kojimahara, Noriko Yamaguchi, Naohito |
author_sort | Endo, Motoki |
collection | PubMed |
description | PURPOSE: More employees are experiencing a cancer diagnosis during their working-age years, yet there have been no large-scale Japanese studies investigating sick leave due to cancer. We clarified differences in the cumulative partial and full return to work (RTW) rates between different cancer types among Japanese cancer survivors. METHODS: Data on Japanese employees who experienced an episode of sick leave due to clinically certified cancer diagnosed between 1 January 2000 and 31 December 2011 were obtained from an occupational health register. Subject outcomes within the 365-day period following their initial day of sick leave were utilized for this study. We investigated the cumulative partial/full and full RTW rates by using survival analysis with competing risks and predictors of time to RTW by a Fine-Gray proportional hazard regression model. RESULTS: One thousand two hundred seventy-eight subjects (1033 males and 245 females) experienced their first episode of sick leave due to cancer during the 12-year follow-up period. Of the subjects, 47.1 % returned to work full time within 6 months of their initial day of sick leave absence, and 62.3 % by 12 months. The cumulative RTW rate varied significantly by cancer type. There were considerable differences in the range of cumulative full RTW rates between the two categories (“lower full RTW rate” groups (“lung,” “hepatic, pancreatic,” “esophageal,” and “blood” cancer groups) vs. “higher full RTW rate” groups (“gastric,” “intestinal,” “breast,” “female genital,” “male genital,” “urinary”): 6.3 to 14.3 % vs. 11.4 to 28.3 % at 60 days, 10.6 to 22.4 % vs. 27.0 to 50.0 % at 120 days, 21.3 to 34.7 % vs. 38.5 to 65.4 % at 180 days, 34.3 to 42.9 % vs. 66.0 to 79.5 % at 365 days). Additionally, older age may be associated with a longer time to full RTW. CONCLUSIONS: More than half of the subjects returned to work full-time within the 365-day period following their initial day of sick leave, with cumulative RTW rates varying by cancer type. Older employees may require a longer time to full RTW. IMPLICATIONS OF CANCER SURVIVORS: It is very important for companies (especially small- and medium-sized companies) to establish and improve their RTW support system for cancer survivors, with knowledge that the median time to RTW is expected to be at least a few months. |
format | Online Article Text |
id | pubmed-4801999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-48019992016-04-06 Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors Endo, Motoki Haruyama, Yasuo Takahashi, Miyako Nishiura, Chihiro Kojimahara, Noriko Yamaguchi, Naohito J Cancer Surviv Article PURPOSE: More employees are experiencing a cancer diagnosis during their working-age years, yet there have been no large-scale Japanese studies investigating sick leave due to cancer. We clarified differences in the cumulative partial and full return to work (RTW) rates between different cancer types among Japanese cancer survivors. METHODS: Data on Japanese employees who experienced an episode of sick leave due to clinically certified cancer diagnosed between 1 January 2000 and 31 December 2011 were obtained from an occupational health register. Subject outcomes within the 365-day period following their initial day of sick leave were utilized for this study. We investigated the cumulative partial/full and full RTW rates by using survival analysis with competing risks and predictors of time to RTW by a Fine-Gray proportional hazard regression model. RESULTS: One thousand two hundred seventy-eight subjects (1033 males and 245 females) experienced their first episode of sick leave due to cancer during the 12-year follow-up period. Of the subjects, 47.1 % returned to work full time within 6 months of their initial day of sick leave absence, and 62.3 % by 12 months. The cumulative RTW rate varied significantly by cancer type. There were considerable differences in the range of cumulative full RTW rates between the two categories (“lower full RTW rate” groups (“lung,” “hepatic, pancreatic,” “esophageal,” and “blood” cancer groups) vs. “higher full RTW rate” groups (“gastric,” “intestinal,” “breast,” “female genital,” “male genital,” “urinary”): 6.3 to 14.3 % vs. 11.4 to 28.3 % at 60 days, 10.6 to 22.4 % vs. 27.0 to 50.0 % at 120 days, 21.3 to 34.7 % vs. 38.5 to 65.4 % at 180 days, 34.3 to 42.9 % vs. 66.0 to 79.5 % at 365 days). Additionally, older age may be associated with a longer time to full RTW. CONCLUSIONS: More than half of the subjects returned to work full-time within the 365-day period following their initial day of sick leave, with cumulative RTW rates varying by cancer type. Older employees may require a longer time to full RTW. IMPLICATIONS OF CANCER SURVIVORS: It is very important for companies (especially small- and medium-sized companies) to establish and improve their RTW support system for cancer survivors, with knowledge that the median time to RTW is expected to be at least a few months. Springer US 2015-08-30 2016 /pmc/articles/PMC4801999/ /pubmed/26318185 http://dx.doi.org/10.1007/s11764-015-0478-3 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Endo, Motoki Haruyama, Yasuo Takahashi, Miyako Nishiura, Chihiro Kojimahara, Noriko Yamaguchi, Naohito Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors |
title | Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors |
title_full | Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors |
title_fullStr | Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors |
title_full_unstemmed | Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors |
title_short | Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors |
title_sort | returning to work after sick leave due to cancer: a 365-day cohort study of japanese cancer survivors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801999/ https://www.ncbi.nlm.nih.gov/pubmed/26318185 http://dx.doi.org/10.1007/s11764-015-0478-3 |
work_keys_str_mv | AT endomotoki returningtoworkaftersickleaveduetocancera365daycohortstudyofjapanesecancersurvivors AT haruyamayasuo returningtoworkaftersickleaveduetocancera365daycohortstudyofjapanesecancersurvivors AT takahashimiyako returningtoworkaftersickleaveduetocancera365daycohortstudyofjapanesecancersurvivors AT nishiurachihiro returningtoworkaftersickleaveduetocancera365daycohortstudyofjapanesecancersurvivors AT kojimaharanoriko returningtoworkaftersickleaveduetocancera365daycohortstudyofjapanesecancersurvivors AT yamaguchinaohito returningtoworkaftersickleaveduetocancera365daycohortstudyofjapanesecancersurvivors |